Assignee
CENTURY THERAPEUTICS INC
US·3 granted patents·14 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
17 records- 0172US2024216429A1Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0268US11883432B2Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·13 claims
- 0368US2025059286A1Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0467US12269888B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·4 claims
- 0563US2025360210A1Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0663US2025066728A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0762US2025090582A1Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0859US2025345425A1Cells engineered with an hla-e and hla-g transgeneCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0958US11661459B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2021·Granted May 30, 2023·0 cites·11 claims
- 1056US2025064934A1Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1156US2023381317A1Methods for controlled activation and/or expansion of genetically engineered cells using polyethylene glycol (peg) receptorsCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1254US2022333073A1Compositions and Methods for Generating Gamma-Delta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1353US2022332782A1Combined Artificial Cell Death/Reporter System Polypeptide for Chimeric Antigen Receptor Cell and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1453US2022331361A1Gene transfer vectors and methods of engineering cellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1551US2022333074A1Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1646US2022184123A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1746US2022195396A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →